• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Transcend Medical

edit

Transcend Medical is focused on the research and development of novel devices for the treatment of glaucoma, the leading cause of adult irreversible blindness. Over two million people in the U.S. alone are afflicted with the disease today and the numbers are expected to grow to three million by the year 2020. The Transcend Medical approach is focused on replacing the current therapies for the treatment of glaucoma with a less invasive procedure and minimal complications.

Milestones

edit

• 
  Transcend Medical received $16M in Series B funding. (1/17/12)
  Posted 1/17/12 at 2:57am via onbiovc.com
• 
  Transcend Medical received $9.4M in Series A funding. (6/22/09)
  Posted 6/22/09 at 10:17am via venturebeat.com
• 
  Transcend Medical received $35M in Series B funding. (6/1/09)
  Posted 6/9/09 at 9:21pm via fiercebiotech.com

Videos

Screenshots

edit

Above: Transcend Medical
Uploaded: 6/10/09

Sources

1. Transcend Medical pockets $35M in VC (fiercebiotech.com) [edit]
2. Transcend Medical sees $20M for glaucoma device (deals.venturebeat.com) [edit]
3. Transcend Medical, Inc.: Series B $16M (onbiovc.com) [edit]